Status:
TERMINATED
A Clinical Trial Comparing The Efficacy And Safety Of 2 Different Initial Dose Prescriptions For Exubera.
Lead Sponsor:
Pfizer
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The primary objective of this study is to assess whether a simple initial dose prescription of inhaled insulin (Exubera) achieves glycemic control (HbA1c) after 16 weeks that is non-inferior compared ...
Eligibility Criteria
Inclusion
- Diabetes mellitus Type 2
- Currently treated with at least 2 oral anti-diabetic agents
Exclusion
- Severe Asthma, severe COPD
- Smoking
Key Trial Info
Start Date :
June 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2007
Estimated Enrollment :
49 Patients enrolled
Trial Details
Trial ID
NCT00437489
Start Date
June 1 2007
End Date
December 1 2007
Last Update
May 11 2009
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Hong Kong, Hong Kong
2
Pfizer Investigational Site
Karachi, Sindh, Pakistan, 74600
3
Pfizer Investigational Site
Makati, Philippines, 1218
4
Pfizer Investigational Site
Marikina City, Philippines, 1810